mlsanityData to 7 Oct 2026

Scaffold-Aware Generative Augmentation and Reranking for Enhanced Virtual Screening

arXiv 2510.16306 ↗First posted 18 Oct 2025cs.LG cs.AIcited by 0

Not on the map. Why?

Abstract (arXiv)

Ligand-based virtual screening (VS) is an essential step in drug discovery that evaluates large chemical libraries to identify compounds that potentially bind to a therapeutic target. However, VS faces three major challenges: class imbalance due to the low active rate, structural imbalance among active molecules where certain scaffolds dominate, and the need to identify structurally diverse active compounds for novel drug development. We introduce ScaffAug, a scaffold-aware VS framework that addresses these challenges through three modules. The augmentation module first generates synthetic data conditioned on scaffolds of actual hits using generative models, specifically a graph diffusion model. This helps mitigate the class imbalance and furthermore the structural imbalance, due to our proposed scaffold-aware sampling algorithm, designed to produce more samples for active molecules with underrepresented scaffolds. A model-agnostic self-training module is then used to safely integrate the generated synthetic data from our augmentation module with the original labeled data. Lastly, we introduce a reranking module that improves VS by enhancing scaffold diversity in the top recommended set of molecules, while still maintaining and even enhancing the overall general performance of identifying novel, active compounds. We conduct comprehensive computational experiments across five target classes, comparing ScaffAug against existing baseline methods by reporting the performance of multiple evaluation metrics and performing ablation studies on ScaffAug. Overall, this work introduces novel perspectives on effectively enhancing VS by leveraging generative augmentations, reranking, and general scaffold-awareness.

Key facts. No citing papers in the map yet (data through 7 Oct 2026). Builds on 24 of its 46 references that are in the map. First posted on arXiv 18 Oct 2025.

Builds on

24 of 46 references.

References · 24

  1. 2020Denoising Diffusion Probabilistic Modelscited by 20,851
  2. 2016Semi-Supervised Classification with Graph Convolutional Networkscited by 11,282
  3. 2017Graph Attention Networkscited by 8,854
  4. 2018How Powerful are Graph Neural Networks?cited by 4,355
  5. 2019Optuna: A Next-generation Hyperparameter Optimization Frameworkcited by 2,455
  6. 2022DiGress: Discrete Denoising diffusion for graph generationcited by 503
  7. 2018MolGAN: An implicit generative model for small molecular graphscited by 392
  8. 2020Permutation Invariant Graph Generation via Score-Based Generative Modelingcited by 263
  9. 2022Structure-based Drug Design with Equivariant Diffusion Modelscited by 213
  10. 2022G-Mixup: Graph Data Augmentation for Graph Classificationcited by 145
  11. 2023Machine Learning for Synthetic Data Generation: A Reviewcited by 118
  12. 2018Multi-Objective De Novo Drug Design with Conditional Graph Generative Modelcited by 101
12 more
  1. 2023InstructMol: Multi-Modal Integration for Building a Versatile and Reliable Molecular Assistant in Drug Discoverycited by 86
  2. 2022Self-Training: A Surveycited by 85
  3. 2022Graph Rationalization with Environment-based Augmentationscited by 70
  4. 2020Robust Optimization as Data Augmentation for Large-scale Graphscited by 58
  5. 2023Conditional Diffusion Based on Discrete Graph Structures for Molecular Graph Generationcited by 46
  6. 2024Graph Diffusion Transformers for Multi-Conditional Molecular Generationcited by 44
  7. 2017Application of generative autoencoder in de novo molecular designcited by 32
  8. 2021Imbalanced Graph Classification via Graph-of-Graph Neural Networkscited by 27
  9. 2023Class-Imbalanced Learning on Graphs: A Surveycited by 24
  10. 2023Data-Centric Learning from Unlabeled Graphs with Diffusion Modelcited by 19
  11. 2024WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarkingcited by 5
  12. 2020Deep Learning for Virtual Screening: Five Reasons to Use ROC Cost Functionscited by 3

Built on by

Not cited yet.

Similar, not cited

Close in wording, no citation either way

  1. 2024TurboHopp: Accelerated Molecule Scaffold Hopping with Consistency Models
  2. 2025From In Silico to In Vitro: Evaluating Molecule Generative Models for Hit Generation
  3. 2025OMTRA: A Multi-Task Generative Model for Structure-Based Drug Design
  4. 2025Toward Closed-loop Molecular Discovery via Language Model, Property Alignment and Strategic Search
  5. 2026Scaffold-Conditioned Preference Triplets for Controllable Molecular Optimization with Large Language Models
  6. 2026Generating Developable 3D Molecules via Pocket-Conditioned Diffusion and Property-Aware Optimization
  7. 2025Generative molecule evolution using 3D pharmacophore for efficient Structure-Based Drug Design
  8. 2025ActivityDiff: A diffusion model with Positive and Negative Activity Guidance for De Novo Drug Design